obesity drug news today glp-1 september 22 2025 Trump announces $50/month weight loss drugs for millions Outlook for obesity in 2025:
Description
Taken together, these results position retatrutide as a breakthrough in comprehensive metabolic care, moving far beyond the limitations of current weight-loss and diabetes medications
N Engl J Med 377:11191131

BioMed Res

The third approach aims to enhance endogenous GLP-1 production from intestinal L-cells
